The Europe breast pumps market size was valued at USD 370.56 million in 2017 and is expected to register a CAGR of 7.9% over the forecast period. The regional product demand is anticipated to witness a surge due to rising women employment rates, various government initiatives aimed at improving consumer awareness, and improving healthcare infrastructure, especially in emerging economies.
Increasing women employment is expected to be a high-impact rendering driver for this market over the forecast period. Working women have a relatively higher disposable income and lesser time to breastfeed their babies, thus boosting the regional product demand. For instance, as per Eurostat, women employment rate increased from 65.3% in 2016 to 66.5% in 2017. It becomes difficult for working women to provide proper nutrition to their babies, which has led to an increase in neonatal mortality. In such cases, breast pumps allow mothers to provide proper nutrition to their babies without hampering their professional life. Hence, increasing women employment rate in Europe is expected to propel the market growth over the forecast period.
High awareness among target consumers, i.e. the awareness among lactating mothers, regarding the advantages of breastfeeding, is projected to create growth opportunities for the Europe breast pumps market over the forecast period. High disposable income coupled with technological advancements are also significant driving factors for the regional market.
Moreover, supportive initiatives undertaken by the governments, such as breastfeeding initiative by UNICEF in U.K., are anticipated to positively influence the growth. As a result of these initiatives, the rate of breastfeeding increased to 43% in 2017 from 32% in 2010, which has led to a rise in regional demand.
On the basis of product, the market has been segmented into open system and closed system breast pumps. The closed system commanded the largest share in the market and is expected to witness the fastest growth over the forecast period owing to the increasing adoption. The product is considered to be safer as compared to the open system variant, which is expected to propel the segment in the forthcoming years. This product provides better protection, ensuring maximum removal of impurities. Moreover, it is easy to clean. Introduction of portable instruments, such as Ameda HygieniKit is expected to drive the market growth over the next six years.
Personal use and hospital grade are the major application segments. Hospital grade breast pumps are expected to witness the fastest growth owing to the rising awareness regarding the benefit of breastfeeding and increasing adoption of the product due to rise in women employment.
Hospital-grade pumps are approved and designed by the Food and Drug Administration as safe for multiple users. These pumps can be used by more than one mothers as they are designed with barriers that prevent cross contamination. Introduction of portable instruments, such as Elite, Lact-e, & SMB by Ameda and Lactina & Symphony by Medela, is expected to further drive the segment over the next six years.
On the basis of technology, the market has been segmented into manual, battery powered and electric breast pumps. The electric commanded the largest market share in 2017 and is expected to witness the fastest growth owing to the increasing inclination towards the technologically advanced products. Moreover, working mothers generally prefer using electric pumps as they can easily extract more milk in lesser time.
Electric pumps can often be quite heavy and noisy, but manufacturers continue to use advanced technology, which helps them create lighter pumps that generate lesser noise. Electric pumps are also available on rent for mothers who cannot afford to buy a new pump and require them for short duration.
Germany dominated the market in 2017 owing to the high breastfeeding rate, increasing awareness, and various initiatives taken by government. In Germany, 14 weeks of paid maternity leave is provided, which can be availed from six weeks before birth till eight weeks after childbirth. This period can be extended to 12 weeks in case of multiple births. In addition, 12 months of parental leave is available with 65.0% of the mother’s salary being paid, and mothers are entitled to unpaid parental leave for up to 3 years. Moreover, once mothers resume work, they are entitled to two 30 minutes breaks at the work place per 8 hours to pump breast milk. Such initiatives are expected to boost breastfeeding in Germany. Thus, driving the market.
Increasing awareness about the benefits of breastfeeding, rise in the number of working women, and increasing dual-income households, are among the essential factors driving the regional market. Current economic slowdown has adversely affected sales, due to an overall decline in disposable income in European households. However, this situation is expected to change in near future as economic conditions are improving and employment rate is gradually rising, thereby increasing the purchasing power, especially in dual-income households. Higher inclination of Europeans toward using technologically advanced devices that make routine tasks simpler and faster is another important factor driving growth.
Prominent key players areAmeda AG; Energizer Holdings, Inc.; Medela AG; Philips; Buettner-Frank GmbH; and Pigeon Corporation. Key players engage in strategic initiatives, such as mergers and acquisitions, partnerships, and product launches to sustain the competition. Increasing funding for R&D is expected to drive the market. For instance, in May 2017, Medela announced that it would conduct in-house clinical trials to increase the accuracy and patient compliance of the device.
Report Attribute |
Details |
Market size value in 2020 |
USD 460.86 million |
Revenue forecast in 2025 |
USD 676.53 million |
Growth Rate |
CAGR of 7.9% from 2018 to 2025 |
Base year for estimation |
2017 |
Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2018 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Products, technology, application, country |
Country scope |
Greece; Italy; Germany; Poland; France |
Key companies profiled |
Ameda AG; Energizer Holdings, Inc.; Medela AG; Philips; Buettner-Frank GmbH, Inc.; Pigeon Corporation |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at regional and country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the Europe breast pumps market report on the basis of products, technology, application, and country:
Product Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)
Open System
Closed System
Technology Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)
Manual
Battery Powered
Electric
Application Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)
Personal Use
Hospital Grade
Country Outlook (Volume, Units; Revenue USD Million, 2014 - 2025)
Greece
Italy
Germany
Poland
France
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.